Skip to main content
. 2023 Jun 10;118(2):476–484. doi: 10.1016/j.ajcnut.2023.06.006

TABLE 2.

General characteristics and dietary intakes of the TUDA study follow-up sample (n = 557)1

Males (n = 187) Females (n = 370) P value2
General characteristics
Age, y 76.3 (75.7, 77.0) 75.4 (74.9, 75.9) 0.018
BMI, kg/m2 28.9 (28.3, 29.4) 27.4 (26.9, 28.0) <0.001
Waist/hip ratio, cm 0.98 (0.97, 0.98) 0.89 (0.89, 0.90) <0.001
Current smoker, n (%) 8 (4) 19 (5) <0.001
Alcohol, units/wk3 7.7 (6.0, 9.4) 2.9 (2.5, 3.4) <0.001
Dietary intakes
Energy (MJ/d)4 8.170 (7.872, 8.468) 7.016 (6.842, 7.190) <0.001
Protein (g/d) 80.8 (78.3, 83.4) 72.0 (70.1, 73.9) <0.001
Fat (g/d) 73.2 (69.9, 76.5) 65.5 (63.3, 67.6) <0.001
 Saturated fat (g/d) 28.9 (27.4, 30.4) 25.4 (24.4, 26.4) <0.001
Carbohydrate (g/d) 226.9 (216.7, 237.0) 191.2 (185.9, 196.6) <0.001
 Sugars (g/d) 92.3 (86.9, 97.6) 86.5 (83.0, 89.9) 0.072
 Fiber (g/d) 22.0 (21.0, 23.1) 19.4 (18.8, 20.1) <0.001
Dietary (poly)phenols5 mg/d mg/1000kcals/d mg/d mg/1000kcals/d
Total (poly)phenols 2336 (2204, 2467) 1281 (1193, 1369) 2256 (2175, 2337) 1416 (1357, 1474) <0.001
 Total flavan-3-ols 608 (556, 650) 336 (306, 365) 708 (674, 741) 435 (413, 457) <0.001
 Total theaflavins + thearubigins 543 (492, 593) 301 (276, 334) 607 (565, 650) 372 (345, 399) 0.114
 Theaflavins 72 (65, 79) 40 (36, 44) 81 (75, 86) 49 (46, 53) 0.047
 Thearubigins 471 (427, 515) 261 (232, 290) 527 (490, 564) 323 (299, 346) 0.109
 Total monomers + proanthocyanidins 536 (499, 573) 295 (270, 321) 627 (598, 656) 386 (366, 405) <0.001
 Monomers 316 (289, 342) 175 (158, 193) 356 (334, 378) 220 (206, 235) 0.002
 Proanthocyanidins 220 (198, 243) 120 (107, 133) 271 (253, 289) 165 (154, 177) <0.001
 Total procyanidins + (epi)catechins 146 (136, 156) 80 (73, 87) 155 (147, 162) 95 (90, 101) <0.001
 Procyanidins 86 (80, 92) 48 (43, 52) 90 (85, 94) 55 (52, 58) 0.004
 Total (epi)catechins 60 (56, 64) 33 (30, 36) 65 (62, 68) 40 (38, 42) <0.001
 Catechins 23 (21, 25) 13 (12, 14) 24 (23, 26) 15 (14, 16) <0.001
 Epicatechins 37 (34, 39) 20 (19, 22) 41 (39, 43) 25 (24, 26) <0.001
Plasma valerolactones (nmol/L)6
PVL1: 5-(Hydroxyphenyl)-γ-VL-sulfate 34.6 (20.7, 48.5) 22.8 (18.9, 26.6) 0.571
 Detected in cohort, n=496 (89%)
PVL2: 5-(4ʹ-Hydroxyphenyl)-γ-VL-3ʹ-glucuronide 23.5 (17.4, 29.7) 33.5 (24.6, 42.3) 0.069
 Detected in cohort, n=345 (62%)
PVL1+2 52.0 (35.1, 68.8) 44.2 (36.2, 52.2) 0.286
 Detected in cohort, n=509 (91%)
PVL3: 5-(5ʹ-Hydroxyphenyl)-γ-VL-3ʹ-glucuronide 8.1 (6.1, 10.1) 10.7 (8.0, 13.3) 0.244
 Detected in cohort, n=178 (32%)
1

Data presented are mean (95% CI) unless otherwise indicated. This study involved a new analysis of existing samples from the Trinity-Ulster-Department of Agriculture (TUDA) cohort (n = 5186) first sampled from 2008 to 2012 for comprehensive health, but not dietary, data. The TUDA follow-up sample comprises about 20% of the original cohort who were followed up for re-investigation from 2014 to 2018 (n = 953); only participants who provided dietary intake data and a corresponding blood sample (n = 557) are included in this analysis.

2

Differences in general characteristics between the groups were assessed using independent samples t test (continuous variables) or chi-square test (categorical variables). Differences in dietary and valerolactone data were analyzed by ANCOVA, adjusting for age, on log-transformed data where appropriate. P value for Dietary (poly)phenols refers to values shown as mg/1000kcals/d. P < 0.05 was considered significant.

3

Alcohol consumer; 1 unit equates to 25 mL spirits, 220 mL beer, or 85 mL wine.

4

Potential misreporting of dietary energy intake was identified as ±30% of the estimated energy requirement (EER) value for each individual. Using this approach, a total of 32% of participants reported energy intakes that were identified as potential over- or under-reporters (full details shown in Supplementary Table 2).

5

Dietary (poly)phenol values obtained using a food frequency questionnaire designed specifically to investigate foods containing (poly)phenols, where participants were requested to state the frequency of consumption for food groups or specific products known to contain (poly)phenols.

6

Plasma valerolactone (PVL) metabolites shown here were present in >30% of the samples analyzed. PVL1+2 refers to participants with detectable PVL1 or PVL2 in plasma, but not necessarily both plasma PVLs.